Viewing nowAprogen Risedronate Sodium Tablets 35 mg (Risedronate Sodium 2.5 Hydrate)
Risedronate Sodium 2.5 Hydrate 40.2mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

MFDS item code 200800319 · Notified 2008.01.08 · Insurance code 645207310
Treatment and prevention of osteoporosis in postmenopausal women and men
This medication is used for the treatment and prevention of osteoporosis in both postmenopausal women and men.
As Risedronate Sodium, 35 mg should be taken orally once a week. Since food can interfere with the absorption of this medication, it should be taken at least 30 minutes before breakfast or at least 2 hours before and after consuming any food or drink during the day. It should be taken upright with a sufficient amount of pure water (170-230 mL) and not chewed or sucked; patients should not lie down for at least 30 minutes after taking it.
The safety and efficacy of this medication in children under 18 years of age have not been established.
This medication is an oral bisphosphonate and is mainly used for the treatment of osteoporosis. It may irritate the upper gastrointestinal mucosa; therefore, caution is required in patients with esophageal disease, gastritis, duodenitis, or ulcers. Severe esophageal adverse reactions such as esophagitis, esophageal ulcers, and esophageal erosion may occur rarely, so if symptoms like difficulty swallowing, pain behind the sternum, or heartburn occur, the medication should be stopped immediately and a doctor should be consulted. This medication must be taken with sufficient water (170-230 mL), and patients should not lie down for at least 30 minutes afterward. Also, food should not be consumed for a period of time before and after taking the medication. Failing to adhere to the administration instructions may greatly increase the risk of esophageal irritation. Furthermore, it's important to take this medication in conjunction with calcium and vitamin D, and patients with metabolic disorders like hypocalcemia, parathyroid dysfunction, or vitamin D deficiency should ensure treatment before use. Women who are pregnant or potentially pregnant, nursing mothers, patients with severe renal impairment, and those with esophageal motility disorders should not use this medication. Bisphosphonate medications have rarely been reported to cause serious side effects such as osteonecrosis of the jaw, atypical femoral fractures, and necrosis of the external auditory canal; if any of these symptoms are suspected, the doctor should be informed immediately. This medication should not be taken with antacids or supplements that contain divalent cations such as calcium, magnesium, iron, or aluminum at the same time, as they can interfere with absorption. Adverse reactions such as fever, myalgia, arthralgia, dyspepsia, diarrhea, and headache may occur during treatment, and if these symptoms are severe or persistent, a consultation with a doctor is necessary. Finally, the safety and efficacy of this medication in children have not been established, and it can be used in the elderly without dose adjustment.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in the mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attacks, respiratory distress associated with cough and fever, jaundice (yellowing of the skin or eyes), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, numbness, and urinary issues.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture. The recommended storage temperature is room temperature between 1 degree and 30 degrees Celsius.
Yellow, elongated film-coated tablet
4 tablets/PTP (4 tablets/PTP × 1)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRisedronate Sodium 2.5 Hydrate 40.2mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Austin Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Nexpam Korea Co., Ltd.

Risedronate Sodium 2.5 Hydrate 35mg
Tablet · Prescription medication
Hyutecs Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.2mg
Tablet · Prescription medication
Celix Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Myeongmun Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Risedronate Sodium 2.5 Hydrate 40.17mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.